All News
EULAR 2019 Report – Day 2
It was a full and lively 2nd day in Madrid with sessions dedicated to Lupus, RA, Sjogren’s, imaging, rare diseases, psoriatic arthritis and spondyloarthritis. Here are a few of the highlights from day 2 EULAR in Madrid
Read Article
The always eloquent Raashid Luqmani holds a full plenary hall entranced with an AAV masterclass #EULAR2019 SP0044 @RheumNow https://t.co/sJ97QswXOY
David Liew drdavidliew ( View Tweet)
Free Special Article in both A&R/AC&R #EULAR19
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis
https://t.co/Ymu64QhV1G https://t.co/9vwfb5CWbZ
ACR_Journals ACR_Journals ( View Tweet)
Schulert, et al showed some beautiful work dissecting what drives monocytes and macrophages to go berzerk during Macrophage Activation Syndrome. Via transcriptional profiling, they find TRIM8 (E3 upiquitinligase) drives excessive IFNγ & is elevated in sJIA pts #EULAR2019 OP0150 https://t.co/A7ziCjcGhC
Dr. John Cush RheumNow ( View Tweet)
How do you treat Takyasu's arthritis at onset?
Janet Pope Janetbirdope ( View Tweet)
How do you treat Hand Osteoarthritis?
Dr. John Cush RheumNow ( View Tweet)
Take a look at one of our posters published during #EULAR2019 about Cannabis-based products for medicinal use in people with #fibromyalgia. #BecomeFibroAware
https://t.co/fvomc315o8 https://t.co/71gPPEsohT
Simon Stones SimonRStones ( View Tweet)
KAWAKINRA Study - Anakinra in IVIG Refractory Kawasaki Disease. #EULAR2019 Abstract OP0147 https://t.co/eVEAKIbho7
Links:
Dr. John Cush RheumNow ( View Tweet)
Useful data regarding switch in RA!
JAKi to TNFi
or
TNFi to JAK
in the one trial #eular2019 https://t.co/2EViLJuCH1
Dr Irwin Lim _connectedcare ( View Tweet)
Nearly 60% of patients with #Arthritis reported using #cannabidiol products to relieve #pain and other symptoms despite limited evidence showing efficacy of these products #EULAR19 https://t.co/Olzwi8ttD8
Healio Rheumatology HealioRheum ( View Tweet)
John Stone reports that 42% of patients maintained treatment-free remission after 1 year of weekly tocilizumab in part 2 of the GiACTA trial. GC exposure over 3 years also lower
#EULAR2019 #GiantCellArteritis https://t.co/XpFyRj9wrx
The Lancet Rheumatology TheLancetRheum ( View Tweet)
REMINDER: TWEETUP🙂 FRIDAY 1500 at STAND V08 BSR #eular2019 https://t.co/JlCg5g4lTj
Dr Irwin Lim _connectedcare ( View Tweet)
TAkayasu's arteritis guidelines. Better studies needed THU0286 #EULAR2019 @RheumNow https://t.co/KQITL1ldtZ https://t.co/iyMsfoIhTl
Janet Pope Janetbirdope ( View Tweet)
Sjogren’s syndrome is associated with lymphoma, but we know not everyone has equal risk. Who should we worry about? Some suggestions from Vall d’Hebron, Barcelona
#EULAR2019 SP0082 Albert Selva-O’Callaghan @RheumNow https://t.co/XAmnZnl2fY
David Liew drdavidliew ( View Tweet)
Georg Schett: The relationship bw facet joint disease and syndesmophytes has previously been recognised. IL23 blockade is very effective on enthaesitis and possibly has effect on axial enthaesitis. #eular2019
Alberta Hoi tuna0sashimi ( View Tweet)
No new safety signals with 7 yrs LTE if Baricitinib in RA. Lack of VTE and Cv signal. THU0078 #EULAR2019 @RheumNow https://t.co/aQDEwqoAk0
Janet Pope Janetbirdope ( View Tweet)
#treatment in #extrarenal #lupus
#EULAR19 https://t.co/IMXzVcieMV
dr hanady manasfi hanadymanasfi ( View Tweet)
How do pts do with CTD ILD after lung transplant. Study shows a trend to less survival than IPF. CTD pts slightly younger 56.5 vs IPF 60 yrs and more females 69% vs 23%. N of each group only 26. PIttsburg found increase early mortality then equal. OP0169 #EULAR2019 @RheumNow https://t.co/7StbQ9U2g8
Janet Pope Janetbirdope ( View Tweet)
“Naming a cancer based on its location is so last century”
https://t.co/JJ8lO97tF5 #EULAR2019
Better to name based on causative mechanism. Check out these drugs approved based on mutation https://t.co/uVTaYYVZpM
Links:
Dr Irwin Lim _connectedcare ( View Tweet)
Holy moly! Goh et al. (2007) Human Disease network is so cool!! RN: in the big data session-Harald Schmidt discusses treatments based on disease networks. A very different approach here- thinking of disease definitions as networks. #EULAR2019 https://t.co/TKmeYRW9Uh
Kayla Amodeo,PhD doc_amodeo ( View Tweet)